Delivery Order SPE2DB22D1002-SPE2DB25FLFD1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 24, 2025. This contract represents a firm fixed price, non-set-aside competitive award issued on July 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.76 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,352.92 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of July 21, 2025. This competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a non-set-aside procurement executed through open competition, consistent with AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,259.24 for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded procurement issued on July 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a specialized acute-use nasal spray medication, indicating this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.44 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract, awarded on July 25, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This non-competed, firm fixed price delivery order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order represents a child contract under...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFD1Delivery Order
The Defense Logistics Agency awarded a $1,129.62 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Valtoco delivery represents the company's continued role as a key supplier of specialized medications to federal healthcare systems, consistent with its extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/22/25 |